Chris Dickson

Chris Dickson is an experienced executive with a strong background in healthcare and technology. Currently serving as Chairman at Cambridge Sleep Sciences Ltd and Executive Chairman at Verso Biosense, Chris focuses on advanced biotechnical product development. Additionally, Chris acts as a Board Advisor for Thalamos, which specializes in mental health care technology. Previously held positions include Director at NINE HEALTH GLOBAL LIMITED, where Chris worked with healthcare big data, and Director of International Strategy at EMIS Group. Chris has also served as a Non-Executive Director at Fidelity Technologies Ltd and its subsidiaries. With a foundational education in Medicine from St Thomas's Hospital Medical School and prior roles at Ascribe Ltd, Chris has demonstrated leadership and operational expertise within the healthcare sector.